Promega Corporation

Aurora A Kinase Enzyme System

See All Kinase Enzyme Systems
Recombinant full-length human Aurora A was expressed by baculovirus in Sf9 cells using an N-terminal GST tag. Aurora A belongs to a multigenic family of mitotic serine/threonine kinases, which are involved in the control of chromosome segregation. Aurora A is involved in centrosome separation, duplication and maturation as well as in bipolar spindle assembly and stability. Aurora A is expressed and active at the highest level during G2-M phase of the cell cycle. Overexpression of Aurora A has been found to be correlated with the grade of various human solid tumors. Ectopic Aurora A o...

Expand to Read More »

  • Share
  • Print
  • Email
  • Prices valid for customers of Promega GmbH only
Product Size Conc. Catalog # *List Price Order QTY Add to Cart

Aurora A Kinase Enzyme System

Close Window

Aurora A Kinase Enzyme System

 Components

10μg
- V1931 zł 1 548,00 Add to cart

Aurora A Kinase Enzyme System

Close Window

Aurora A Kinase Enzyme System

 Components

1mg
- V1932 zł 23 843,00 Add to cart

ADP-Glo™ Kinase Assay + Aurora A Kinase Enzyme System

Close Window

ADP-Glo™ Kinase Assay + Aurora A Kinase Enzyme System

 Components

  • Aurora A Kinase Enzyme System

    V19311 x 10μg
  • ADP-Glo™ Kinase Assay

    V91011 x 1,000 assays
1 each
- V9081 zł 3 139,00 Add to cart


You Also May Be Interested In

Storage Conditions

Upon receipt, centrifuge the kinase and dispense it into smaller quantities. Store the kinase at –70°C and the rest of the components at –20°C.

For product intended use please see Patents & Disclaimers tab.

Use Restrictions

V1931, V1932, V9081 For Research Use Only. Not for Use in Diagnostic Procedures.

Patents - Disclaimers

V9081 U.S. Pat. Nos. 7,083,911, 7,452,663 and 7,732,128 and other patents.

V9081 U.S. Pat. No. 7,700,310 and other patents and patents pending.

V9081 U.S. Pat. No. 7,741,067 and other patents and patents pending.

V9081 U.S. Pat. Nos. 6,602,677, 7,241,584 and 8,030,017 and other patents and patents pending.

V9081 U.S. Pat. No. 8,183,007 and other patents pending.

V9081 Licensed from Lonza Nottingham Ltd. under U.S. Pat. Nos. 6,599,711 and 6,911,319 and other pending and issued patents.

V9081 The method of recombinant expression of Coleoptera luciferase is covered by U.S. Pat. Nos. 5,583,024, 5,674,713 and 5,700,673.

Prefer a different language?

Your country is set to Poland. Your language is set to polski. Please select the language that will best suit your needs:

This is correct, continue to site »

I need additional help

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.